Severe sepsis is not clinically apparent during the first 24 hours of hospitalization in most children with cancer and febrile neutropenia (FN), delaying targeted interventions that could impact mortality. The aim of this study was to prospectively evaluate biomarkers obtained within 24 hours of hospitalization as predictors of severe sepsis before it becomes clinically evident. Methods: Children with cancer, admitted with FN at high risk for an invasive bacterial infection in 6 public hospitals in Santiago, Chile, were monitored throughout their clinical course for occurrence of severe sepsis. Clinical, demographic and 6 biomarkers ͓eg, blood urea nitrogen, serum glucose, lactic dehydrogenase, serum C-reactive protein (CRP), interleukin (IL)-8, and procalcitonin͔ were obtained at the time of admission and after 24 hours. Biomarkers independently associated with severe sepsis diagnosed after the first 24 hours of hospitalization were identified by logistic regression analysis. Results: A total of 601 high risk FN episodes were enrolled between June 2004 and October 2006; 151 (25%) developed severe sepsis of which 116 (77%) were not clinically apparent during the first 24 hours of hospitalization. Risk factors for severe sepsis were age Ն12 years ͓odds ratio (OR): 3.85; 95% confidence interval (CI): 2.41-6.15͔, admission CRP Ն90 mg/L (OR: 2.03; 95% CI: 1.32-3.14), admission IL-8 Ն200 pg/mL (OR: 2.39; 95% CI: 1.51-3.78), 24-hour CRP Ն100 mg/L (OR: 3.06; 95% CI: 1.94 -4.85), and 24-hour IL-8 Ն300 pg/mL (OR: 3.13; 95% CI 1.92-5.08). Conclusions: Age Ն12 years and admission or 24-hour values of CRP Ն90/100 mg/L and IL-8 Ն200/300 pg/mL are predictors of
D
uring the past decade, there has been considerable progress in the management of patients with cancer, fever, and neutropenia. The development and validation of risk prediction models for episodes at low or high risk for invasive bacterial infections (IBI) have had a significant impact in favoring selective management strategies. [1] [2] [3] [4] [5] Current models have been most successful in the early identification of low risk episodes, demonstrating high sensitivity and negative predictive values (NPV), supporting nonaggressive managements for these patients. 6 -13 By contrast, approximately 70% of children admitted with febrile neutropenia (FN) are at high risk for an IBI, and these children have a 25% chance of developing severe sepsis, defined as a systemic inflammatory response syndrome in the presence, or as a result of, suspected or proven infection, plus organ dysfunction. 14 -16 Children who present with high risk FN have a risk of death of approximately 3%, and deaths are universally accompanied by a diagnosis of severe sepsis. 17 Current models of risk prediction have not been as successful in discriminating between high risk episodes that will have a favorable outcome from those that will develop with severe sepsis and/or cause the death of the child. 4, 5, 17 Early identification of the subgroup of children who are developing severe sepsis, before it is clinically evident, can aid in selectively targeting these children for highly aggressive management and monitoring in an intensive care unit (ICU) setting.
Laboratory tests associated with severe outcomes such as bacteremia, sepsis, or infection-associated death have been evaluated in patients with FN. 18 -21 In an adult population, interleukin (IL)-8 serum values Ͼ2000 pg/mL had a sensitivity of 53% and specificity of 97% as a predictor of Gram-negative bacteremia 18 ; also in adults, increased values of blood urea nitrogen (BUN), blood glucose, and serum lactic dehydrogenase (LDH) have been associated with an increased risk for death. 19 In children, IL-6 of 2100 pg/mL and IL-8 of 960 pg/mL showed a sensitivity of 63% and specificity of 99% for predicting Gram-negative bacteremia in 56 children who had 121 episodes of FN. 20 In a retrospective study of 51 children with 122 episodes of FN, serum procalcitonin (PCT) levels of 0.5 g/L were more sensitive and specific (60% and 85%, respectively) than C-reactive protein (CRP), IL-6, and IL-8 for diagnosis of Gram-negative bacteremia. 21 Our aim was to prospectively evaluate 6 biomarkers (eg, BUN, blood glucose, LDH, CRP, IL-8, and PCT) 18 -22 obtained within 24 hours of hospital admission as predictors of severe sepsis before it becomes clinically evident.
METHODS
Patient Selection. This prospective, government-sponsored, multicenter study included children Յ18 years of age with cancer, fever, and severe neutropenia defined as an absolute neutrophil count (ANC) Յ500/mm 3 , admitted to any of 6 major public hospitals located in Santiago, Chile, participating in the National Child Program of Antineoplastic Drugs (PINDA). Children were evaluated within the first hour after hospital admission by a study physician who classified the episode as low or high risk for IBI according to a previously validated risk prediction model. This model considers type of cancer, number of days since the end of the last chemotherapy, arterial blood pressure, platelet count, and serum CRP. 4, 5 Children with low risk episodes were managed in the hospital for 24 hours followed by ambulatory management; these children were excluded from this study. Children with high risk episodes and their families were invited to participate and written informed consent was obtained. Evaluation at Admission. The following information was obtained: age, gender, type of cancer and chemotherapy, hours of fever before admission, and use of granulocytic colony stimulator factor (G-CSF) and central venous catheter. Clinical and laboratory evaluation included temperature (°C), physical examination, neurologic status (Glasgow coma score), blood pressure, complete blood count, central and peripheral blood cultures, chest radiograph, urine analysis and culture. Nasopharyngeal aspirate for respiratory viruses and cultures from other sites were obtained, if clinically indicated. Serologic markers studied were BUN, blood glucose, LDH, CRP, IL-8, and PCT. Management and Follow-Up. Children were diagnosed and treated according to the Chilean National Consensus on the rational approach toward cancer patients with FN. 23 Antimicrobial selection was based on a common protocol for all hospitals as established by the PINDA working group; patients received an initial antimicrobial regimen, a third generation cephalosporin with or without an aminoglycoside, and an antistaphylococal ␤ lactam. [23] [24] [25] Axillary temperature, blood pressure, capillary refill, Glasgow coma score, urinary output, and blood oxygen value were monitored every 8 hours during the first 48 hours, and then daily until discharge. 18, 20 PCT was determined by immunochemiluminescence using a commercial kit, LUMItest PCT, B.R.A.H.M.S Diagnostica (Berlin, Germany). 21 Statistical Analysis. Patients baseline characteristics were summarized using descriptive statistics: mean Ϯ SD for continuous variables and percentages for categorical variables.
Because our aim is to aid in advancing a diagnosis of severe sepsis before it is clinically evident, episodes with a clinical diagnosis of severe sepsis made by treating physicians during the first 24 hours of hospitalization were excluded for the analysis. Univariate analysis was used to compare biomarkers between episodes with severe sepsis diagnosed after 24 hours of hospitalization versus episodes without severe sepsis.
Continuous variables were compared by analysis of variance or Kruskal-Wallis test if variances were unequal. Noncontinuos variables were compared by 2 or Fisher exact test. Clinically useful cutoff values were calculated for each significant test value by receiving operator constructing curves. Significant variables with their corresponding cutoff values were then included in a stepwise logistic regression model to select variables that were independently associated with severe sepsis not clinically apparent during the first 24 hours of hospitalization. Odds ratio, sensitivity, specificity, positive predictive value, and NPV were calculated and used to identify clinically useful biomarkers. Relative risk was used to compare risk groups. All statistical analyses were performed with the Epi Info Program, Version 3.3.2, CDC and Prevention (Atlanta, Georgia). One hundred fifty-one episodes (25%) developed severe sepsis and 450 episodes (75%) resolved without developing severe sepsis. In 35 episodes severe sepsis was diagnosed during the first 24 hours of hospitalization by treating physicians and thus excluded from analysis. Biomarkers were evaluated in 566 episodes; the 116 episodes of severe sepsis not clinically apparent during the first 24 hours of hospitalization and the 450 episodes without severe sepsis. The 566 high risk episodes included in the analysis occurred in 278 children distributed as follows: 143 children presented 1 episode, 60 children presented 2 episodes, 26 children presented 3 episodes, 24 children presented 4 episodes, and 25 children presented 5 or more episodes.
RESULTS

Population
Children who developed severe sepsis not clinically apparent during the first 24 hours of hospitalization were significantly older (Table 1) . Cancer type, hours of fever before admission, use of G-CSF, and use of a central venous catheter did not differ between groups. Episodes that developed severe sepsis were overall admitted with a lower Glasgow coma score, but 96% of these children had a normal Glasgow coma score at admission. Direct admission and overall admission to ICU were more common in the group developing severe sepsis but over half of these were never admitted to an ICU. Duration of fever, neutropenia (ANC Ͻ500/mm 3 ), and monocytopenia (acute monocyte count ͓AMC͔ Ͻ100/mm 3 ) was more prolonged in episodes developing severe sepsis; all children who died had a diagnosis of severe sepsis. Microbiology Results. One or more microorganisms were detected in 35% of the 566 high risk episodes; 56% and 30% in the episodes with and without severe sepsis (P Ͻ 0.001), respectively ( Table 2 ). The great majority (Ͼ90%) of microorganisms detected in severe septic episodes were obtained from sterile sites, mostly blood (81%). Episodes not presenting severe sepsis had a higher detection of viruses (16% versus 1%, P ϭ 0.0004). Bacterial species distribution did not differ significantly between the 2 groups. Biomarkers Associated With Severe Sepsis. Four of the 6 targeted admission biomarkers, BUN, blood glucose, CRP, and IL-8, were significantly associated with occurrence of severe sepsis not clinically apparent during the first 24 hours by univariate analysis (Table 3) . Admission LDH and PCT levels did not differ among groups. At 24 hours BUN lost and PCT gained significance. Two of 3 nontargeted hematologic indices obtained at admission also resulted in difference between the 2 groups; for example, AMC and platelet counts were significantly lower in the severe septic episodes: AMC 50.3 Ϯ 169.1 versus 99.6 Ϯ 398.7, P ϭ 0.003; platelets (ϫ10 3 ) 38.9 Ϯ 49.8 versus 59.5 Ϯ 87.3, P ϭ 0.03. ANC did not differ between groups (85.6 Ϯ 151.9 versus 88.2 Ϯ 152.3, P ϭ 0.8).
We made a second analysis, considering only 1 episode per child, in the 278 enrolled children: 98 severe septic versus 180 nonsevere septic children. IL-8 at admission and after 24 hours, as well as blood glucose and PCT at 24 hours, remained significant. Serum CRP maintained the trend albeit loosing significance with this lower sample (P ϭ 0.18 and 0.07 at admission and 24 hours, respectively).
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Significant biomarkers, independently associated with severe sepsis according to their best discriminative cutoff value after logistic regression analysis are shown in Table 4 . A cutoff value for platelet count that could significantly aid in differentiating severe sepsis from nonsevere sepsis was not found and was thus not included in the logistic regression analysis. A significant and independent cutoff value of 40/mm 3 was detected for AMC ͓odds ratio (OR): 2.01; 95% confidence interval (CI): 1.17-3.48͔. This extremely low value of AMC was considered of unclear clinical relevance by the study team and was thus not included in the analysis of variable combinations. BUN and PCT were not independently significant at any time point. Age was a variable that discriminated strongly between both groups. Severe sepsis occurred in 19% of children Ͻ12 years of age and in 40% of children Ն12 years of age (OR: 3.85; 95% CI: 2.41-6.15). Hours of fever before admission did not explain this difference as it did not differ significantly among these 2 age categories (8.1 Ϯ 10.5 versus 6.6 Ϯ 10.6, P ϭ 0.14). Admission values of blood glucose, serum CRP, and IL-8 of 120 mg/dL, 90 mg/L, and 200 pg/mL, respectively, best discriminated severe septic episodes, slightly higher values of CRP, and IL-8 best discriminated at 24 hours, whereas the blood glucose lost significance at this time period.
We selected the 3 most significant and consistent variables at admission and/or after 24 hours (age, CRP, and IL-8); choosing for clinical simplicity the same value of CRP and IL-8 for both time periods: CRP Ն90 mg/L and IL-8 Ն300 pg/mL. The proposed biomarker combination allowed significant discrimination between groups at different risk for severe sepsis not clinically apparent during the first 24 hours, ranging from 8% to 33% in children Ͻ12 years of age and from 23% to 73% among children Ն12 years of age (Table 5) .
DISCUSSION
In this large prospective trial of children with FN at high risk for IBI, episodes developing with severe sepsis not clinically apparent within the first 24 hours of hospital admission differed from episodes developing without severe sepsis in 1 demographic variable: age; in 5 of 6 targeted serologic biomarkers: BUN, blood glucose, CRP, IL-8, and PCT; and in 2 nontargeted hematological indices: AMC and platelet count. After a thorough analysis of these variables intended to select those most consistently discriminative within 24 hours of admission and useful for clinical practice, we identified 3 variables independently associated with severe sepsis not clinically apparent during the first 24 hours of hospitalization (eg, age Ն12 years, CRP Ն90 mg/L, and IL-8 Ն300 pg/mL).
Less than 1 in 10 FN episodes occurring in children Ͻ12 years of age who present CRP and IL-8 below the cutoff values at admission and/or 24 hours will develop a severe sepsis during hospitalization; more than 50% of the episodes in young children will be in this category. The high NPV of FN occurring in children Ն12 years of age represented 20% of episodes in our study, somewhat lower than the proportion of 35% reported in another study. 26 These children were at a significantly higher risk for severe sepsis and our proposed model discriminated a group that has a risk for severe sepsis close to 20%, a large group with a risk close to 50%, and a small albeit significant group that has a risk surpassing 60%. The significant risk in the latter 2 groups merits direct admission into the ICU, close monitoring for early signs of severe sepsis, and aggressive management as soon as they are detected.
Longer length of stay and increased death has been reported for adolescents with FN supporting an increased risk for this age group. 26 The increased risk for severe sepsis in our study does not seem to be explained, at least grossly, by a delay in consultation among this age group compared with younger children (P ϭ 0.14). On the other hand, the spectrum of malignancies that occur in adolescents is distinctive when compared with those that occur in young children, and the 5-year outcome in those 15-19 years old with leukemia and sarcoma is worse than in younger patients. 27 In this study, we did not identify the differences in malignancies that could explain the higher risk for severe sepsis in children Ն12 years of age (data not shown). This high-risk group should be targeted for future studies aimed to specifically determine host and external risk factors associated with an increased risk for severe sepsis. Our data provides opportunities for public health education efforts directed toward parents, adolescents, and health professionals.
CRP and IL-8 but not PCT proved to be useful predictors for severe sepsis not clinically apparent during the first 24 hours in children admitted with FN at high risk for IBI. This large prospective study advances from previous studies by excluding low risk episodes and by focusing on a defined serious outcome, severe sepsis. In this context, serum CRP levels obtained at the time of admission and after 24 hours provides additional benefit over its previously recognized value as predictor for high risk of IBI.
4,5 IL-8 determinations provided significant additional predictive value and in combination with CRP proved to be clinically useful. These results are supported by a number of studies that demonstrate that this biomarker increases in presence of a more severe infectious process. 28, 29 Conversely, the low usefulness of PCT seems discordant with results from other studies. 21, 30, 31 The comparative analysis between studies must be performed cautiously as populations and outcomes are different. In our experience, based on 566 episodes already screened and selected for their high risk for IBI, PCT was not useful for further discrimination of severe sepsis. PCT may be useful in absence of screening and/or for monitoring the clinical course of infection. 31 In light of our findings, universal implementation of PCT detection for children with FN will not be of significant benefit over CRP and IL-8 for early identification of severe sepsis.
A previous model of risk for IBI identified 30% of low-risk FN episodes that can be managed with short hospital stay and ambulatory treatment. 13 We now propose, based on a large prospective trial, for the other 70% at high risk for IBI, a selective strategy based on clinical examination and combined evaluation of age, IL-8, and CRP. A critical requirement was to design a relatively simple and clinically useful combination; there is room for improvement, especially in younger children in whom prediction did not surpass 33%. The search for new biomarkers capable of detecting an early host response to a severe infection will need to continue; new gene expression systems of host genes up-regulated or downregulated are in the horizon. 32 In the meantime, prospective validation of our proposed biomarkers in different pediatric settings will be required; if these validations prove to be consistent, considerable benefit for children and health care systems can be expected. 
